J Bone Miner Res. 2015 May;30(5):929-33. doi: 10.1002/jbmr.2410.
We conclude that the effects of bisphosphonates on fracture prevention in osteogenesis imperfecta are inconclusive. Adequately powered trials with a fracture endpoint are needed to further investigate the risks and benefits of bisphosphonates in this condition.
Autor: Hald JD, Evangelou E, Langdahl BL, Ralston SH.